European Union Trademark No. 001810845 (Word) Trademark register: EUIPO Status: registration expired

Word mark

The European Union Trademark for OCATA (Word) was filed on 16.08.2000 for goods and services in class(es) 35 and 42 at the European Union Intellectual Property Office (EUIPO). The current status of the trademark No. 001810845 OCATA is 'registration expired'.

Trademark information
RegisterEuropean Union Intellectual Property Office (EUIPO)
Filing date16.08.2000
Registration date14.08.2003
Expiry date16.08.2010
Nice classes35 and 42
RepresentativeMARKS & CLERK LLP
 WC2E 9RA London, GB
Goods and Services (the trademark is registered for the following goods and services)
Class 35 : The operation of a business which sells to users scientific instrumentation such as mass spectrometers, electrophoresis analyzers, separation apparatus such as liquid chromatographs and capillary electrophoresis apparatus, optical detection systems such as ultraviolet, fluorescence and chemiluminescence detectors, microfluidic apparatus, and sample preparation apparatus.
Class 42 : Consultancy services relating to the development of assays for the diagnosis of diseases; consultancy services relating to the development of chemical markers which indicate the presence of disease states; consultancy services relating to performing diagnostics for diseases, namely analysing and reporting on patient specimens; consultancy services relating to determining biological targets for drugs, namely determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; consultancy services relating to determining protein and peptide sequencies, for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; consultancy services for developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services, and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; all the aforesaid services being consultancy services in the field of healthcare.... More
tmdb is a free trademark search website of publicly available records. tmdb does not guarantee nor warrant the accuracy, completeness or timeliness of the data.